Searched for
HEXAXIM
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
- Best medicine for volatile times: Don’t buy a stock, buy a business; 5 pharma stocks with upside potential of up to 43%Don’t buy a stock, buy a business, says our headline. It’s not as easy as it sounds. But it’s not too difficult either. While there are sev...
- As headwinds slow & managements become realistic, time for a relook: 5 mid-cap pharma stocks with upside potential of up to 44%Every sector goes through a phase when managements become over-optimistic, taking decisions that should have been avoided. But then, with t...
- Think bullish, but learn to live with & ignore volatility: 5 stocks from different sectors with an upside potential of up to 42%The probability of a correction if there is no positive development on the India-US trade deal is quite high. The fact, however, remains th...
- Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...
- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI...
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...
- Forget additional 2.5% LTCG, finally it is economy and earnings: 4 midcap stocks from different sectors with an upside potential of up to 37%The reaction of the street to the increase in both short and long capital gains tax is stronger because it was not expected by any section ...
- These 5 pharma stocks can give more than 24% returns in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
- Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
- Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...
- High ROE & Net Profit Margin, two key elements of long-term wealth creatorsA high return on equity is a result of two factors. First, the basic nature of the business, there are some businesses that require a const...
- Vaccine explainer: I am fully vaccinated. When do I need a booster?The worst way to determine when boosters are needed would be to wait for infection rates to rise in vaccinated people. It would be the simp...
- Are companies bribing doctors to push vaccine combos?Paediatricians question these huge price increases with the addition of just one more vaccine.
Load More
